Topics
AMD
Clinical Trial Closeup
Coding & Medicare
DME
Editor's Page
Genetics
Imaging & Diagnostics
News
RVO
Stem Cells
Surgical Pearl Video
Surgical Techniques & Tools
Uveitis
Vitrectomy
Current Issue
Archive
CME
News
Popular Alzheimer's Drug May Help Prevent AMD
Calling out retina’s ‘head-in-the-sand’ approach to mental health and neovascular AMD
Five events make for a busy summer in retina
In the Lucentis biosimilars wars, there are no winners so far
Study reports potential of OCT to identify vascular damage in severe COVID-19
With FDA approval, pegcetacoplan launches with high awareness—and a few questions
Why are ophthalmologists a definite maybe about biosimilars? Survey provides answers
A deeper dive into anti-VEGF loss to follow-up: Study identifies risk factors
Where are the women in retina? Not at the podium, study reports
Bevacizumab first, aflibercept second cost-effective for DME, Protocol AC finds
With Byooviz, Biogen takes a leap on pricing first U.S. retina biosimilar
New DME treatment trial targets underrepresented populations
A deeper dive into why DAZZLE results of KSI-301 in nAMD ‘disappointed’
Retina Update: Is Vabysmo the next $1 billion anti-VEGF?
Retina Update: Market forces may be gathering to exert price pressures on anti-VEGF drugs
Retina Update: New research challenges previous findings on genetic risk factor for AMD
Retina Update: Finnish researchers add voice to cataract surgery in AMD debate
Retina Update: NEI-supported group is tackling ophthalmology’s diversity problem
Retina Update: COVID-19 dealt retina surgical procedures a big blow; effects may linger for a while
Retina Update: Now director of National Eye Institute, Dr. Michael Chiang comes full circle
Load More
Current Issue
Table of Contents
Digital Edition
PDF Edition
Archives
Subscription
Connect With Us
Continuing Medical Education
Breaking New Ground: Reducing Treatment Burden in nAMD
CME Monograph
View More CME
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
View More Publications
Review Of Ophthalmology
Table of Contents
Digital Edition
PDF Edition
Archives
Subscription
Is The “Shiny and New” Right for You?
How to Succeed with the New Triple Procedure
Solving Dry-Eye Conundrums
×
Full Image